Effect of colchicine compared with placebo on high sensitivity C-reactive protein in patients with acute coronary syndrome or acute stroke: a pilot randomized controlled trial

article

Effect of colchicine compared with placebo on high sensitivity C-reactive protein in patients with acute coronary syndrome or acute stroke: a pilot randomized controlled trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S11239-011-0637-Y
P698PubMed publication ID21918905

P50authorJohn W. EikelboomQ42846212
P2093author name stringMark Nidorf
Qilong Yi
Rajesh Hiralal
Nick D. Fagel
Nina C. Raju
P2860cites workUpdate on colchicine and its mechanism of actionQ28217460
Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery diseaseQ28220518
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive proteinQ29547752
Pharmacological and clinical basis of treatment of Familial Mediterranean Fever (FMF) with colchicine or analogues: an update.Q34395824
C-reactive protein and other inflammatory biomarkers as predictors of outcome following acute coronary syndromesQ35806401
C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task ForceQ37608837
What have we learned about the biology of atherosclerosis? The role of inflammation.Q43762451
C-reactive protein levels and outcomes after statin therapyQ45213511
Colchicine interferes with L-selectin and leukocyte function-associated antigen-1 expression on human T lymphocytes and inhibits T cell activationQ57985213
Similarities between platelet contraction and cellular motility during mitosis: role of platelet microtubules in clot retractionQ67783554
Effect of mitosis inhibitors on blood platelet microtubules and aggregationQ71837605
Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery DiseaseQ73088403
Inflammatory markers of coronary riskQ73088431
Extracellular matrix modulates macrophage functions characteristic to atheroma: collagen type I enhances acquisition of resident macrophage traits by human peripheral blood monocytes in vitroQ74351464
Pathology of the vulnerable plaqueQ83187650
P433issue1
P921main subjectacute coronary syndromeQ266018
placeboQ269829
(S)-(−)-colchicineQ326224
randomized controlled trialQ1436668
P304page(s)88-94
P577publication date2011-09-15
P1433published inJournal of Thrombosis and ThrombolysisQ15766541
P1476titleEffect of colchicine compared with placebo on high sensitivity C-reactive protein in patients with acute coronary syndrome or acute stroke: a pilot randomized controlled trial
P478volume33

Reverse relations

cites work (P2860)
Q38560160Colchicine as an anti-inflammatory and cardioprotective agent.
Q38942364Colchicine for prevention and treatment of cardiac diseases: A meta-analysis.
Q24186361Colchicine for prevention of cardiovascular events
Q24198220Colchicine for prevention of cardiovascular events
Q38178536Colchicine for secondary prevention of cardiovascular disease
Q26796341Colchicine in cardiac disease: a systematic review and meta-analysis of randomized controlled trials
Q38780826Colchicine in cardiovascular disease: an ancient drug with modern tricks
Q37070180Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout.
Q28082473Colchicine--Update on mechanisms of action and therapeutic uses
Q36384995Colchicine: old and new
Q36578681Effect of Colchicine on Platelet-Platelet and Platelet-Leukocyte Interactions: a Pilot Study in Healthy Subjects
Q36751637Effect of IMOD™ on the inflammatory process after acute ischemic stroke: a randomized clinical trial
Q93232759Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel
Q38851472Immune-mediated mechanisms of atherosclerosis and implications for the clinic
Q38241233Improving cardiovascular and renal outcomes in gout: what should we target?
Q93270056Plasma Metabolic Signature of Atherosclerosis Progression and Colchicine Treatment in Rabbits
Q99633698Short-term effect of low-dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high-sensitivity C-reactive protein
Q39206224Teaching an Old Dog New Tricks: Colchicine in Cardiovascular Medicine
Q38985092What's Old is New Again - A review of the current evidence of colchicine in cardiovascular medicine

Search more.